Detalles de la búsqueda
1.
Multi-institutional phase II study on the feasibility of liver resection following preoperative mFOLFOX6 therapy for resectable liver metastases from colorectal cancers.
Int J Clin Oncol
; 22(2): 316-323, 2017 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-27752787
2.
[A Case of Long-Term Survival of a Patient with Gastric Cancer with Synchronous Liver Metastasis and Portal Vein Thrombus after Multidisciplinary Treatment].
Gan To Kagaku Ryoho
; 44(6): 521-523, 2017 Jun.
Artículo
en Japonés
| MEDLINE | ID: mdl-28698446
3.
Conversion to complete resection with mFOLFOX6 with bevacizumab or cetuximab based on K-RAS status for unresectable colorectal liver metastasis (BECK study): Long-term results of survival.
J Hepatobiliary Pancreat Sci
; 27(8): 496-509, 2020 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-32362018
4.
Conversion to complete resection with mFOLFOX6 with bevacizumab or cetuximab based on K-ras status for unresectable colorectal liver metastasis (BECK study).
J Hepatobiliary Pancreat Sci
; 22(8): 634-45, 2015 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-25926024
Resultados
1 -
4
de 4
1
Próxima >
>>